Academic Malignant Hematologists

Academic Malignant Hematologists, Division of Medical Oncology and Hematology

Princess Margaret Cancer Centre, University Health Network (Assistant/Associate/Full Professor)

Clinician Investigator, Teacher, Quality & Innovation

The Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre, University Health Network (UHN) is seeking to recruit 3 to 4 energetic and innovative physicians with expertise in malignant hematology; bone marrow transplant, leukemia, lymphoma and/or myeloma.  Each successful applicant will have an academic position description of Clinician Teacher, Quality & Innovation, or Investigator.  Each successful applicant must be eligible for a Full Time Clinical Academic appointment at the rank of Assistant Professor or higher.  The anticipated start date is September 1, 2021, or shortly thereafter. 

Each successful applicant will have a demonstrated passion for the medical care of cancer patients as well as a strong interest in teaching and/or quality improvement.  The successful applicant will join a multidisciplinary team in the management of patients with hematological malignancies within a comprehensive cancer centre setting and, will be expected to engage in clinical, translational, or basic research. Other responsibilities include teaching at the undergraduate and postgraduate levels.

The Malignant Hematology Program within the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre is the largest such program in Canada, and is among the largest in North America. Comprised of about thirty senior physicians, the Malignant Hematology Program is supported by outstanding institutional infrastructure including hematopathology, cytogenetics and molecular diagnostics programs led by a wide medical and allied health multidisciplinary team.  The program supports extensive clinical, translational, and basic research initiatives including a large clinical trials program. Additionally, the Division of Medical Oncology and Hematology supports a comprehensive training program attracting both national and international fellows.

The Princess Margaret Cancer Centre includes the Princess Margaret Research Institute, (formerly known as the Ontario Cancer Institute - OCI), a world-class basic and translational research institute with particular strengths in hematopoiesis, immunology, stem cell biology, cancer biology, and cell therapeutics. The close association between clinicians and scientists within the Princess Margaret Cancer Centre and Princess Margaret Research Institute,  provides the opportunity for collaborations on disease biology and the development of innovative and informative translational studies, allowing the applicant to achieve the goal of bench-to-bedside medicine. In addition, the Princess Margaret Cancer Centre supports active and widely-recognized clinical trials and drug development programs, and maintains a state-of-the-art GMP (Good Manufacturing Practice) cell processing facility. The Princess Margaret Cancer Centre is affiliated with the University of Toronto, which is world-recognized for programs in areas including biochemistry, immunology, stem cell biology, genomics, proteomics, and cell processing, among others. Princess Margaret Cancer Centre is a teaching hospital, dedicated to educating the world’s future top cancer experts.  Our role as an internationally respected teaching hospital keeps us and our students abreast of the latest medical developments and the most advanced technology. 

Each successful candidate will fulfil the academic position description of Clinician Investigator, Clinician in Quality & Innovation or Clinician Teacher.  For applicants being considered for appointment as a Clinician Teacher, excellence will be assessed by the presence of scholarly contributions to teaching and education as evidenced by pedagogical innovation, curriculum development, experience in teaching at the undergraduate and graduate level, and teaching awards. For Clinician Investigators, scholarly excellence will be assessed by the presence of research grants, publications in leading journals, invited presentations at significant conferences, awards, accolades, and other related accomplishments.  Each successful applicant must also hold a MD degree as well as specialist designation in Clinical Hematology or Medical Oncology, or equivalent. Each successful applicant must also have, or be eligible for both registration with the College of Physicians and Surgeons of Ontario and FRCPC qualifications.  Academic rank, salary and contractual arrangements will be commensurate with the qualifications and experience of the successful candidate. A highly attractive remuneration package is available.

Should you be interested in this opportunity, please forward your covering letter, curriculum vitae, and the names and addresses of three referees to:

Dr. Amit Oza - Chief, Division of Medical Oncology and Hematology
c/o Ewa Amarelo, Administrator
Princess Margaret Cancer Centre, University Health Network
Suite 7-925, 700 University Avenue, Toronto, Ontario, Canada, M5G 1Z5
Office: 416.946.4501 x 5661
Fax: 416.946.2082 E-mail: ewa.amarelo@uhn.ca

Applications will be accepted until July 15, 2021, or until all positions are filled.  The first rolling interviews will start after the initial July 15, 2021 application closing date.

For more information on the Princess Margaret Cancer Centre and our world-recognized programs, visit: www.theprincessmargaret.ca.

 

For more information about the Department of Medicine at the University of Toronto, please visit our website at http://www.deptmedicine.utoronto.ca. The Department of Medicine’s academic position descriptions can be viewed on this webpage: http://www.deptmedicine.utoronto.ca/academic-position-descriptions#AcademicPositionDescriptions.

The University of Toronto is strongly committed to diversity within its community and especially welcomes applications from racialized persons / persons of colour, women, Indigenous / Aboriginal People of North America, persons with disabilities, LGBTQ persons, and others who may contribute to the further diversification of ideas.

All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.